article · BMC Oral Health
Endocan demonstrates specificity as a biomarker for peri-implantitis, showing capacity to differentiate advanced peri-implant pathology from healthy tissues and peri-implant mucositis. These results suggest Endocan's potential utility for disease staging and monitoring in peri-implant care, providing a foundation for biomarker-based diagnostic approaches in implant dentistry.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12903-025-06633-8
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
